Description

TRUGLIF MET 12.5/1000 MG
Overview: Truglif Met 12.5/1000mg Tablet is a combination of Empagliflozin (12.5 mg) and Metformin (1000 mg). It is used to treat type 2 diabetes by helping to control blood sugar levels and reduce the risk of cardiovascular events. Empagliflozin, an SGLT2 inhibitor, increases glucose excretion in the urine, while Metformin improves insulin sensitivity.
Uses and Benefits:
Type 2 Diabetes Management: Helps control blood sugar levels in adults with type 2 diabetes.
Cardiovascular Protection: Reduces the risk of cardiovascular death in people with type 2 diabetes and established cardiovascular disease.
Insulin Sensitivity: Metformin improves insulin sensitivity and reduces glucose absorption in the intestines.
Glucose Excretion: Empagliflozin increases glucose excretion through urine, helping lower blood sugar.
Dosage and Administration:
Take as prescribed by your healthcare provider, usually one tablet daily with meals.
Side Effects:
Nausea
Diarrhea
Urinary tract infections
Increased urination
Precautions:
Inform your doctor if you have a history of kidney or liver disease.
Regularly monitor blood sugar levels while on this medication.
Follow dietary and exercise guidelines from your healthcare provider.